(0.05%) 5 102.59 points
(0.20%) 38 315 points
(0.09%) 15 941 points
(-1.30%) $82.76
(6.19%) $2.04
(0.07%) $2 348.80
(-0.22%) $27.48
(3.83%) $957.45
(-0.20%) $0.933
(-0.30%) $10.99
(-0.53%) $0.796
(1.67%) $93.41
-2.41% £ 40.50
Live Chart Being Loaded With Signals
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally...
Stats | |
---|---|
Tagesvolumen | 216 849 |
Durchschnittsvolumen | 215 038 |
Marktkapitalisierung | 51.23M |
EPS | £0 ( 2024-04-11 ) |
Last Dividend | £0.0400 ( 2018-05-24 ) |
Next Dividend | £0 ( N/A ) |
P/E | 40.50 |
ATR14 | £0.452 (1.11%) |
Venture Life Group PLC Korrelation
10 Am meisten positiv korreliert |
---|
10 Am meisten negativ korreliert |
---|
Wussten Sie das?
Korrelation ist ein statistisches Maß, das die Beziehung zwischen zwei Variablen beschreibt. Es reicht von -1 bis 1, wobei -1 eine perfekte negative Korrelation (wenn eine Variable zunimmt, nimmt die andere ab) anzeigt, 1 eine perfekte positive Korrelation (wenn eine Variable zunimmt, nimmt die andere zu) und 0 keine Korrelation anzeigt (es besteht kein Zusammenhang zwischen den Variablen).
Korrelation kann verwendet werden, um die Beziehung zwischen beliebigen zwei Variablen zu analysieren, nicht nur zwischen Aktien. Es wird häufig in Bereichen wie Finanzen, Wirtschaft, Psychologie und mehr verwendet.
Venture Life Group PLC Finanzdaten
Annual | 2023 |
Umsatz: | £51.41M |
Bruttogewinn: | £13.51M (26.27 %) |
EPS: | £0.00730 |
FY | 2023 |
Umsatz: | £51.41M |
Bruttogewinn: | £13.51M (26.27 %) |
EPS: | £0.00730 |
FY | 2022 |
Umsatz: | £43.98M |
Bruttogewinn: | £17.67M (40.17 %) |
EPS: | £0.00410 |
FY | 2021 |
Umsatz: | £32.76M |
Bruttogewinn: | £12.96M (39.55 %) |
EPS: | £0.0278 |
Financial Reports:
No articles found.
Venture Life Group PLC Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
£0 (N/A) |
First Dividend | £0.0400 | 2014-06-11 |
Last Dividend | £0.0400 | 2018-05-24 |
Next Dividend | £0 | N/A |
Payout Date | 2018-06-22 | |
Next Payout Date | N/A | |
# dividends | 5 | -- |
Total Paid Out | £0.200 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.4 | -- |
Div. Sustainability Score | 8.11 | |
Div.Growth Potential Score | 4.20 | |
Div. Directional Score | 6.15 | -- |
Year | Amount | Yield |
---|---|---|
2014 | £0 | 0.00% |
2015 | £0 | 0.00% |
2016 | £0 | 0.00% |
2017 | £0 | 0.00% |
2018 | £0.0400 | 0.10% |
2019 | £0 | 0.00% |
2020 | £0 | 0.00% |
2021 | £0 | 0.00% |
2022 | £0 | 0.00% |
2023 | £0 | 0.00% |
2024 | £0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
VCAP.L | Dividend Knight | 2023-09-14 | Semi-Annually | 4 | 3.56% | |
MRCH.L | Dividend King | 2023-07-06 | Quarterly | 53 | 3.07% | |
DLN.L | Dividend Knight | 2023-09-07 | Semi-Annually | 32 | 1.77% | |
SHG.L | Dividend Knight | 2023-11-02 | Semi-Annually | 4 | 0.91% | |
IHP.L | Dividend Knight | 2023-06-08 | Semi-Annually | 7 | 1.08% | |
BOCH.L | Dividend Junior | 2023-05-04 | Insufficient data to determine frequency | 2 | 1.10% | |
OCN.L | Dividend Knight | 2023-05-18 | Annually | 19 | 3.96% | |
ESNT.L | Dividend King | 2023-09-21 | Semi-Annually | 20 | 4.44% | |
STAN.L | Dividend Junior | 2023-08-10 | Annually | 32 | 1.92% | |
JMAT.L | Dividend Knight | 2023-06-08 | Semi-Annually | 33 | 1.93% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0179 | 1.500 | 9.64 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.00771 | 1.200 | 9.74 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0123 | 1.500 | -0.975 | -1.462 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 1.084 | 0.800 | 9.58 | 7.67 | [1 - 3] |
quickRatioTTM | 0.735 | 0.800 | -0.380 | -0.304 | [0.8 - 2.5] |
cashRatioTTM | 0.189 | 1.500 | -0.0587 | -0.0880 | [0.2 - 2] |
debtRatioTTM | 0.204 | -1.500 | 6.60 | -9.90 | [0 - 0.6] |
interestCoverageTTM | 3.00 | 1.000 | -0.00174 | -0.00174 | [3 - 30] |
operatingCashFlowPerShareTTM | 0.0540 | 2.00 | 9.98 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 0.0350 | 2.00 | 9.98 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.320 | -1.500 | 8.72 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.263 | 1.000 | 8.95 | 8.95 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0865 | 1.000 | -0.271 | -0.271 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.280 | 1.000 | 9.56 | 9.56 | [0.2 - 2] |
assetTurnoverTTM | 0.430 | 0.800 | -0.465 | -0.372 | [0.5 - 2] |
Total Score | 8.11 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 57.00 | 1.000 | 4.34 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0123 | 2.50 | -0.627 | -1.462 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 0.0350 | 2.00 | 9.99 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 0.0540 | 2.00 | 9.98 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 77.45 | 1.500 | 10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.133 | 1.000 | 9.18 | 0 | [0.1 - 0.5] |
Total Score | 4.20 |
Venture Life Group PLC
Venture Life Group plc develops and commercializes oral care products, food supplements, medical devices, dermo-cosmetics, and topical products for the ageing population in the United Kingdom, the Netherlands, China, Germany, Italy, Switzerland, rest of Europe, and internationally. It operates through Venture Life Brands and Customer Brands segments. The company offers neurology products, including NeuroAge, NeuroAge Sleep, and NeuroAge NRG food supplements to enhance alertness, cognitive function, and mental performance in healthy brain; and Original Bioscalin to treat and prevent hair loss, hair thinning, and baldness. It also provides Fungal Nail Solution, which helps to treat and prevent fungal infections; and Fungal Nail Cleanser for the hygiene of hands and feet prone to fungal nail infections under the Myco Clear brand name. In addition, the company offers UltraDEX product for bad breath; Dently Dual Action, a mouthwash, which lifts and removes plaque and bacteria from the teeth and gums; and Procto-eze plus for anal irritation, including haemorrhoids condition. Further, it provides women healthcare products comprising vonalei bacterial vaginosis, a refreshing gel; vonalei Vaginal Atrophy, a vaginal cream; vonalei candidiasis, a soothing cream-gel for thrush; and vonalei intimate cleansing foam. Additionally, it offers Cleansing Foam, Cleansing Cream, and Serum under the Rosa calma brand name; and skincare ranges to hydrate, nourish, and recondition the skin, as well as to prevent the lines and wrinkles under the Lubatti Classic and the Lubatti Anti-age brand names. The company sells its products through a network of international partners, retail pharmacies, as well as grocery multiple retailers. Venture Life Group plc was incorporated in 2005 and is headquartered in Bracknell, the United Kingdom.
Über Live-Signale
Die Live-Signale auf dieser Seite helfen dabei zu bestimmen, wann man NA kaufen oder verkaufen soll. Die Signale haben eine Verzögerung von bis zu 1 Minute; wie bei allen Marktsignalen besteht die Möglichkeit von Fehlern oder Fehleinschätzungen.
Die Live-Handelssignale sind nicht endgültig und getagraph.com übernimmt keine Verantwortung für Maßnahmen, die aufgrund dieser Signale ergriffen werden, wie in den Nutzungsbedingungen beschrieben. Die Signale basieren auf einer breiten Palette von technischen Analyseindikatoren.